NPEs are coming to the life sciences industries. And that could be a good thing
A study released last Friday by Professor Robin Feldman and Harvard Fellow Dr Nicholson Price predicts that biopharmaceutical companies are about to become the next targets for “patent trolls”.
Entitled Patent Trolling: Why Bio & Pharmaceuticals…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.